Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-15 10:52
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering 2025-01-15 02:01
ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS 2025-01-14 21:00
Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma 2025-01-13 22:05
CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial 2025-01-13 21:50
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI) 2025-01-13 08:00
Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of Obesity 2025-01-11 01:30
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology 2025-01-10 22:00
Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases 2025-01-10 21:01
Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease Portfolio 2025-01-10 15:00
SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA 2025-01-10 14:40
In 2024, Complete Genomics expanded U.S. manufacturing and technology capabilities toward a diversified, reliable supply chain for its flexible and cost-effective NGS solutions 2025-01-10 01:43
Hengdian Group Capital and Apeloa Pharmaceutical to participate in 2025 J.P. Morgan Healthcare Conference 2025-01-09 22:00
RiDYMO® Designs Cyclic Peptide for "Undruggable" β-Catenin Target Within Two Months 2025-01-09 12:35
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development 2025-01-09 08:57
111, Inc. Announces ADS Ratio Change 2025-01-08 18:00
GenScript Biotech Becomes a PSCI Supplier Partner, Advancing a Sustainable Pharmaceutical Supply Chain 2025-01-08 11:30
Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease 2025-01-07 22:00
Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing 2025-01-07 21:00
U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application 2025-01-07 18:00
1 2 3 4 5 170